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Abstract 
Background: Cardiovascular diseases are the most common cause of deaths in Iran and other developing countries. 
The risk factors for cardiovascular diseases are divided into two categories; the variable risk factors and the non-
variable risk factors. Many recent studies evaluated the relationship between higher eosinophilia and allergy levels 
with the incidence, progress and severity of cardiovascular diseases, but the exact correlation between these two still 
remains  unknown. The current study was designed to assess the relationship between allergic responses and 
eosinophilia amongst patients with cardiovascular diseases in Ilam province, in comparison with healthy individuals. 
Materials and Methods: In this case-control study, we enrolled 59 cardiovascular patients and 55 healthy 
individuals without any history of allergy and parasitic infections. A questionnaire including questions about 
demographic data, family history of heart disease, history of diabetes, hyperlipidemia, physical activity, smoking, 
stress, dietary fat consumption, salt intake, allergies to certain substances, history of parasitic disease and history of 
hypertension was completed. The blood was taken from each participant and CBC and IgE titer were measured. 
Results: There was a significant relationship for the variables such as the family history of cardiovascular disease 
(P<0.001), diabetes (P<0.003), hyperlipidemia (P<0.0001), high blood pressure (P<0.0001) and physical activity 
(P<0.0001) between the case and the control groups. The mean IgE titer in case group was 95.3±71 and 62.44±49 
in control group. The mean eosinophilia level in peripheral blood was 3.95±1.057 in case and 1.53±0.57 in control 
group. The difference between the IgE and eosinophilia levels in the case and the control groups was statistically 
significant (P<0.0001). Conclusion: Based on our results, it can be concluded the increase in levels of IgE and 
eosinophilia can be considered by cardiologists as a reliable diagnostic tool for predicting cardiovascular diseases. 
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Cardiovascular diseases (CVD) are the most 
common cause of deaths worldwide and also in 
developing countries, and nowadays it has been 
reported as the cause of death of about 20 to 30 
percent of the population in Iran and around the 
world [1-3]. These diseases impose high costs on the 
economy of countries, for example more than 450 
billion dollars were spend by the United States in this 
regard [4, 5]. Although cardiovascular diseases and 
related –risk factors have the same pattern around the 
world, the average age of onset is higher in developed 
countries, because of the public health and clinical 
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efforts [6-8]. Most low and medium income countries 
(LIMIC) and even Iran, are in a state of 
"epidemiological transition”, and the age onset is 
lower in developing countries. Notably, the average 
age of onset and the resulting mortality in Iran is 
lower than the world average in the recent 10 years, 
hence it has become a serious threat to public health 
[3, 9-13]. 
Risk factors of heart diseases include two 
categories of modifiable factors, such as 
hypertension, smoking, hyperlipidemia, sedentary 
lifestyle, diabetes, stress, pollution and drug therapy  
and unchangeable factors such as old age, male sex, 
the black race and family histories of cardiovascular 
diseases [13-15]. However, there is still a great deal 
of uncertainty about the major risk factors in patients 
with cardiovascular diseases [16]. 
Several studies reported the possible 
association between allergic reaction history and 
increased peripheral blood eosinophilia with 
cardiovascular diseases, [17-20]. This possible 
connection was firstly described by Kounis and 
Zefras in 1991. The symptoms of myocardial 
ischemia associated with allergic reactions is called 
"Kounis syndrome" or allergic myocardial infarction 
[21-23]. Recent studies suggest that coronary 
capillary contraction during an allergic reaction is 
induced by secretory inflammatory mediators of 
eosinophils and basophils, such as histamine and 
neutral protease [24, 25]. These inflammatory 
mediators are involved in inducing spasm and 
making atrumatus plaques or destroying coronary 
arteries, and they are the cause of acute coronary 
syndromes and have also been investigated as 
therapeutic targets [22, 26, 27]. In recent studies 
some cases with myocardial injury have been 
observed as clinical protests due to severe 
anaphylactic reactions, with regards to transfusion of 
amoxicillin (clavulanic acid). However, based on the 
cardiologic studies no obstruction or involvement of 
coronary artery have been found, but prick test for 
amoxicillin is positive and anaphylaxis can be the 
cause of myocardial injury, and its mechanism is 
similar to vasospasm induced by basophil mediators  
and mast cells [28-30]. 
In recent years, increased level of serum 
immunoglobulin-E (IgE) in cardiovascular diseases 
has become an attractive issue of researchs [31]. 
Studies show that the probability of acute coronary 
syndrome in atopic patients is higher than in normal 
people [29, 31]. Chriqui et al. in a population-based 
study found that the incidence of myocardial infarction 
and cardiovascular diseases in patients with high 
levels of IgE, significantly increased [32]. It still 
remains unclear whether increased levels of IgE can be 
considered as an indicator of the occurrence of 
cardiovascular problems, particularly coronary heart 
diseases in the future, or it can be introduced as a risk 
factor in ischemic heart disease, and perhaps as an 
indicator of inflammatory and injury responses of 
heart muscles due to antibodies [31]. However, the 
assessment of significant changes in the concentration 
of total serum IgE levels in ischemic heart problems 
and coronary capillary conflicts have been considered 
in comparison with normal IgE levels. 
The new findings suggest that allergies and 
hyper eosinophilia syndrome (HES) can be a major 
risk factor for cardiovascular diseases, and many 
connections have been shown between allergy and 
increased level of peripheral blood eosinophilia, 
cardiac insufficiencies and acute cardiovascular 
problems in various studies [33-36]. Considering the 
possibility of a link between allergy and increased 
peripheral blood eosinophilia syndrome and a variety 
of cardiovascular diseases, the clarification of this 
issue can be effective in preventing heart diseases and 
applying treatment methods, This study is aimed at 
evaluating allergic responses in relation to the level of 
serum IgE antibody as well as peripheral blood 
eosinophil in cardiovascular patients in compared with 
healthy subjects. 
Methods 
This study was conducted in Ilam, Iran. The 
population of the study was 114, amongst which 59 of 
them were cardiac patients (29 men and 30 women), 
with a mean age of 37.12±61.64, who were in CCU of 
Mustafa Khomeini hospital in Khomeini city, Ilam, 
Iran, and 55 were healthy subjects (25 men and 30 
women), with a mean age of 91.23±38.51 with no 
history of allergy and parasitic disease. The calculation 
of sample size was performed using the software Epi-
info and was under the Stat Calculation which use for 
case-control study. Based on 25% incidence of 
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cardiovascular disease in the society, with 99% 
confidence, 59 subjects were calculated for case 
group. This number was also chosen as a control 
group. It should be noted that the maximum 
consistency in demographic characteristics such as 
age, sex and other variables in choosing between the 
two groups were considered as well. In this study, all 
participants were interviewed based on a 
standardized questionnaire containing personal and 
demographic information, and lifestyle. Then 
,approximately 7 cc blood were taken in order to 
counting the number of peripheral blood eosinophil 
and frequency of IgE antibody titers .t The counting 
of peripheral blood eosinophil number and frequency 
of IgE antibody titers were measured using complete 
blood counting (CBC) by Cell Counter - mind ray -
BC 2800 and the ELISA kit IgE (Biomerio), 
respectively. Level of 5-1% of peripheral blood 
eosinophils was as normal and those higher than 5 
percent were higher than normal and levels of IgE 
lower than IU/ml 188 were as normal and those 
higher than IU/ml 188 were as the above the normal 
range. In addition, no cross-reaction was observed 
with other antibody isotopes and all Missing data 
were reviewed. 
Statistical analysis. All results were analyzed 
using SPSS version 15 and chi-square tests and 
independent t-test were performed in order to the 
examination of the prevalence of different categorical 
variables and survey of mean variables values, 
respectively. The P value less than 0.05 (<0.05) is 
expressed as statistically significant. 
Results 
In this study, the titer of IgE antibody and the 
number of cells of peripheral blood eosinophils in 
cardiovascular patients were compared with control 
group. Also, the data analysis between the two groups 
included other variables, such as mean of age, mean of 
BMI, gender, education, occupation, family history of 
heart disease, history of diabetes, hyperlipidemia, 
physical activity, smoking, stress, dietary fat 
consumption, salt intake, allergies to certain 
substances, history of parasitic disease and history of 
hypertension. These were compared and analyzed, and 
data from the completed questionnaires are given in 
table 1. 
Then, the mean of serum IgE titer and all the 
variables in the examined population were analyzed It  
was found that the average level of IgE was significantly 
different in only four cases. A significant difference in 
the mean frequency of IgE titers between the two groups 
was seen in dietary fat intake (P=0.009), salt 
consumption (P=0.006), and allergies against certain 
substances (P= 0.006), as well as history of hypertension 
(P= 0.003). However, no significant differences were 
observed in term of other variables. 
Additionally, the number of peripheral blood 
eosinophils in the studied population was analyzed. In 
this study, the only significant difference observed in this 
Table 1: Evaluation of difference of variables between the control group and sample group. 
 
(P value) Cases Controls Variables  
0.7 64.61±12.31 23.91±51.38 Mean of Age ( year) 
0.071 49.2% 45.4% male   Sex 
50.8% 54.6% female  
0.033 24.23±3.97  21.9±2.31  (BMI)Body mass index  
0.001 28.8 5.5 Family history of heart disease ()%  
0.003 18.6 1.8 History of diabetes ()%  
0.0001 23.7 0 History of Hyperlipidemia )%(  
0.003 69.5 5.5 History of Hypertensions )%( 
0.0001 39 7.3 Levels of physical activity ()%  
0.001 5.4 23.8 High intake of salt in food ()%  
0.001 40.7 9.1 High stress levels ()%  
0.001 27.1 7.3 High fat intake ()%  
0.001 169.61±71.12  62.44 ±49.42   The mean IgE titers (IU/ml) 
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population, was in the number of peripheral blood 
eosinophils in comparable physical activity (P=0.037), 
while in the two other variables, the difference between 
the two groups were so close. The difference between 
the two groups in terms of salt intake in the diet 
(P=0.079) and in terms of gender (P=0.071) were so 
close, with respect to the number of peripheral blood 
eosinophils. 
The difference between mean concentration of 
IgE was statistically significant (P=0.001), as in patients 
with cardiovascular diseases, it was 12.71±61.169 
IU/ml, whereas it was 42.49±44.62 IU/ml in the control 
group.  
Also, a comparison between the average number 
of peripheral blood eosinophils in the two groups 
showed that it was statistically significant (P=0.001) 
(3.95±1.057 per/mm3 in case group and 573.0±53.1 
057 per/mm3 in the control group). 
Discussion 
In the present study, we showed that the 
prevalence of IgE titers and number of peripheral 
blood eosinophils in cardiovascular diseases 
compared with the control group was significantly 
increased. However, it is still unclear whether the 
increased levels of IgE, can be considered as a 
marker in the future for cardiovascular problems, 
especially coronary artery disease or can be 
introduced as a risk factor for ischemic heart. Also 
there is still obscure issue contribution as probable 
indicator in inflammatory and injury responses 
against heart muscle. The results showed that total 
serum IgE level in ischemic heart patients is 
significantly higher than the control group. Thus, 
increased density of serum IgE levels in cardiac 
ischemia patients can be as an indicator of allergic 
reactions in atherogenesis and myocardial ischemia. 
Moreover, our findings of increase in peripheral 
blood eosinophils suggests that the ecological 
reasons (vegetation variety in this region), genetics 
reasons, increased sensitivity to drugs, food, lifestyle 
agricultural products, the possibility of allergic 
reactions and increase in peripheral blood eosinophils 
may be involved in incidence , appearance and 
development of various cardiovascular diseases. 
Along with evaluating of frequency of IgE 
titer and number of peripheral blood eosinophils, 
other variables were also analyzed. Incidence of 
cardiovascular disease were also analyzed according to 
gender and sex influence on the incidence of CVD. In 
the current study 29 men, and 30 women  were 
selected for the control group , the gender effect was 
not statistically important. Whereas, it was shown that  
gender is an important variable in CVD and it can be 
considered as specific risk factors for its occurrence, 
hence gender differences should be noticeable in the 
prevention and treatment [37]. Some literatures also 
show no significant difference between the severity of 
the stroke, symptoms, infraction value and the location 
between two genders [38]. 
Bazanov et al. in China, after the unification of 
variables such as age, sex, physical activity, residence, 
geographic diversity, smoking and diabetes among the 
case and control groups, showed that, increasing BMI  
is again as an important and independent risk factor 
for the occurrence of ischemic and hemorrhagic  
infarctions and it has been shown significant 
differences in increasing mortality due to 
cardiovascular diseases in Chinese citizens between 
the two groups [39] and it was consistent with our 
results.  
There was also a significant link between the 
occurrence of cardiovascular diseases and family 
history of heart diseases in case and control groups, 
which was also observed in Paskvarla study in Italy 
[40]. 
Another finding of this study was a significant 
correlation between the occurrences of cardiovascular 
diseases based on history of diabetes in studied 
groups. This finding is similar to other studies such as 
the study of Howit et al. in Norway and Gomes et al in 
Spain [41, 42]. In the case of diabetes, the possibility 
of incidence and risk of development coronary artery 
diseases is 2-4 times higher, because it seems that in 
spite of hypertension, hyperlipidemia, obesity, 
endothelial damage and reduced function of the 
coagulation factors in diabetes mellitus type II, it has 
destroyed beneficial and protective hormones that can 
prevent coronary heart disease. 
There was no significant association in this 
study regarding the occurrence of cardiovascular 
diseases and history of hyperlipidemia in the case and 
control groups. The study of Macce Duaie et al, in 
Greece showed a significant difference in term of total 
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cholesterol, LDL and lipoprotein lipase (α) among 
children with family history of CVD and CHD and 
the control group. They were aimed at evaluating the 
relation of CVD with history of hyperlipidemia, lipid 
profiles in children with positive family history of 
CVD and CHD incidence, and hyperlipidemia 
compared with healthy controls to determine risk 
factors for cardiovascular diseases [43].  
In this study, the relationship between, blood 
pressure, and high input edible salt with a significant 
risk of incident CVD is significantly comparable and 
show that the increase in blood pressure can cause 
atherosclerosis and can be considered as a major risk 
factors for cardiovascular disease as it causes the 
62% of heart attacks and 49% of acute coronary 
diseases. The studies Wang et al. in China, and Hue 
et al, demonstrated that there was a significant 
association between the occurrence of cardiovascular 
diseases, hypertension, and high input edible salt, 
which was partly in line with our findings [44, 45]. 
Notably, we found that the there was an 
inverse relationship between physical activity and all 
causes of death due to CVD and CAD, which can be  
reinforced by study of Haynl et al. [46]. 
 Based on this study, mental stress as one of 
the variables associated with CVD incidence is 
statistically significant as well. It is an important risk 
factor in the development and incidence of CVD 
which can cause disorder in endothelial function, 
myocardial ischemia, thrombosis and malignant 
cardiac arrhythmias. It was similar to studies of  
Merez et al. [47] and Vale [48]. 
Others found a significant relationship 
between the incidence of cardiovascular diseases and 
a history of allergies to specific substances. Kounis et 
al, investigated the relationship between allergies and 
cardiovascular diseases in term of coronary artery 
spasm induced by histamine and allergic angina in 
Greece. They reported that histamine is the main 
amine release in allergic reactions and can cause 
coronary artery spasm and produce clinical protests 
as an angina pectoris which is consistent with our 
results [21]. 
Interestingly, a significant relationship 
between the frequency of the IgE titers and number 
of peripheral blood eosinophils was shown based on 
studied variables in the case and control groups in 
which there is a significant differences among the 
mean serum IgE titers and fat consumption in the diet, 
salt intake, hypertension, history of allergy to specific. 
To our knowledge, until now, no study reported the 
relationship between these variables and the mean 
serum IgE. Although, the exact reason underlying this 
association   is still unknown, it seems that the 
allergies to certain substances may increase IgE levels 
in the case group.  
Noticeably, it was found that about 66.7% of 
people whose eosinophils count are higher than 
normal ones, are immobility, while only 3.21% of 
those with normal eosinophil are low motion and this 
difference is meaningful. Accordingly, it seems likely 
that physical inactivity and immobility lifestyle are 
more probable among subjects with high number of 
eosinophil, while the number of normal eosinophils is 
high in most people with physical movement and 
exercise. We would like to stress that we reported 
possible association between immobility lifestyle and 
lack of physical activity and increasing the risk of 
peripheral blood eosinophilia for the first time. Also, 
we reported for the first time that the increased salt 
intake was observed among individuals with high 
eosinophils and subjects with high eosinophils have 
used 50% salt, whereas those with normal eosinophil 
have used only 15.7 % salt in their food. Collectively, 
it is possible that increasing consumption of salt in the 
diet can lead to peripheral blood eosinophilia. 
Conclusion 
W showed that the difference between IgE titers 
and number of peripheral blood eosinophils between 
the patient and control groups is significant. Also, it 
appears that the allergic reactions and increase in 
peripheral blood eosinophils contributes to high 
susceptibility to cardiovascular diseases. Hence, high 
levels of IgE antibodies and eosinophilia can be 
considered as an indicator in the development and the 
progression of various types of cardiovascular 
diseases. However, further studies are needed to 
establish efficacy of our findings . 
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